Andrew Zhuang Wang, MD, of the UNC Lineberger Department of Radiation Oncology, was published in the journal Nanoscale. The paper, “Nanoparticle delivery of chemosensitizers improve chemotherapy efficacy without incurring additional toxicity,” was accepted by the journal Jan. 4. Wang and other researchers demonstrated proof of the principle of using a nanoparticle formulation for drugs that improve the sensitivity of tumors to chemotherapy.
